Regenerative Medicine Unit, Bone and Musculoskeletal Research Programme, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, United Kingdom.
Hum Gene Ther. 2010 Oct;21(10):1226-38. doi: 10.1089/hum.2010.173.
Mesenchymal stromal/stem cells (MSCs) are a population of stromal cells present in the bone marrow and most connective tissues, capable of differentiation into mesenchymal tissues such as bone and cartilage. MSCs are attractive candidates for biological cell-based tissue repair approaches because of their extensive proliferative ability in culture while retaining their mesenchymal multilineage differentiation potential. In addition to its undoubted scientific interest, the prospect of monitoring and controlling MSC differentiation is a crucial regulatory and clinical requirement. Hence, the molecular regulation of MSC differentiation has been extensively studied. Most of the studies are in vitro, because the identity of MSCs in their tissues of origin in vivo remains undefined. This review addresses the current knowledge of the molecular basis of differentiation of cultured MSCs, with a particular focus on chondrogenesis and osteogenesis. Building on the information coming from developmental biology studies of embryonic skeletogenesis, several signaling pathways and transcription factors have been investigated and shown to play critical roles in MSC differentiation. In particular, the Wnt and transforming growth factor-β/bone morphogenetic protein signaling pathways are well known to modulate in MSCs the molecular differentiation into cartilage and bone. Relevant to the emerging concept of stem cell niches is the demonstration that physical factors can also participate in the regulation of MSC differentiation. Knowledge of the regulation of MSC differentiation will be critical in the design of three-dimensional culture systems and bioreactors for automated bioprocessing through mathematical models applied to systems biology and network science.
间充质基质/干细胞(MSCs)是存在于骨髓和大多数结缔组织中的基质细胞群体,能够分化为间充质组织,如骨和软骨。MSCs 因其在培养中具有广泛的增殖能力,同时保持其间充质多能分化潜能,成为生物细胞为基础的组织修复方法的理想候选者。除了其毋庸置疑的科学兴趣外,监测和控制 MSC 分化的前景是一个至关重要的监管和临床需求。因此,MSC 分化的分子调控已被广泛研究。由于体内 MSCs 在其组织来源中的身份尚未确定,因此大多数研究都是在体外进行的。本综述讨论了培养 MSC 分化的分子基础的最新知识,特别关注软骨形成和成骨作用。在胚胎骨骼发生发育生物学研究的信息基础上,已经研究了几种信号通路和转录因子,并证明它们在 MSC 分化中发挥关键作用。特别是 Wnt 和转化生长因子-β/骨形态发生蛋白信号通路已被证明可以调节 MSC 向软骨和骨的分子分化。与干细胞生态位的新兴概念相关的是,证明物理因素也可以参与 MSC 分化的调节。了解 MSC 分化的调控对于通过应用于系统生物学和网络科学的数学模型设计用于自动化生物处理的三维培养系统和生物反应器至关重要。